EXCEED THE SPACE PROVIDED. Genetic Variation in B-Lymphocyte Ontogeny Whether they lead to cancer, aging, or both, somatic mutations are usually detrimental to the individual. Mutations at the immunoglobulin (Ig) loci are an exception, because they generate high-affinity antibodies, which are important in memory responses to pathogens. Thus, in the segments of immunoglobulin genes that encode the variable regions of antibodies, mutations are beneficial. Since such mutations arise at a rate a million times higher than the normal, spontaneous mutation rate at other loci, the process is called hypermutation. With our experiments we seek to define cis- and trans-acting elements for hypermutation at the immunoglobulin loci. But hypermutation is not the only change mature B lymphocytes undergo. Small, resting B lymphocytes all start out producing IgM antibodies. Upon encountering antigen, the cells become activated and make a switch from IgM to other immunoglobulin classes. This class switch serves to distribute a particular variable (V) region to different Ig constant (C) regions. Each C region mediates a specialized effector function, so an organism can guide its antibodies to various sites through switching. Creating the new heavy chain (H) gene requires loop-out and deletion of DNA between switch regions. Both hypermutation and class switching require transcription, presumably so that necessary factors can gain access to the DNA. The requisite factors include the cytidine deaminase AID and components of general DNA repair. Yet many important factors remain to be discovered, especially those that may guide recombination to a particular subclass. In the proposed work, we want to study the various splice form of AID and assess their physiological functions; study a chromatin remodelling factor that binds to AID; and study the structure of a newly discovered protein and its function in DNA double-strand-break repair. PERFORMANCE SITE ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG020684-18
Application #
6943035
Study Section
Immunobiology Study Section (IMB)
Program Officer
Fuldner, Rebecca A
Project Start
1987-04-01
Project End
2007-08-31
Budget Start
2005-09-01
Budget End
2007-08-31
Support Year
18
Fiscal Year
2005
Total Cost
$331,875
Indirect Cost
Name
University of California San Francisco
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Parsa, Jahan-Yar; Basit, Wajiha; Wang, Clifford L et al. (2007) AID mutates a non-immunoglobulin transgene independent of chromosomal position. Mol Immunol 44:567-75
Wang, Clifford L; Yang, Desiree C; Wabl, Matthias (2006) Slow, stochastic transgene repression with properties of a timer. Genome Biol 7:R47
Wang, Clifford L; Wang, Bruce B; Bartha, Gabor et al. (2006) Activation of an oncogenic microRNA cistron by provirus integration. Proc Natl Acad Sci U S A 103:18680-4
Wang, Clifford L; Wabl, Matthias (2005) Hypermutation rate normalized by chronological time. J Immunol 174:5650-4
Klasen, Maik; Spillmann, Freia J X; Marra, Giancarlo et al. (2005) Somatic hypermutation and mismatch repair in non-B cells. Eur J Immunol 35:2222-9
Glud, Sys Zoffmann; Sorensen, Annette Balle; Andrulis, Mindaugas et al. (2005) A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus. Blood 106:3546-52
Wang, Clifford L; Wabl, Matthias (2005) Mutational activity in cell line WEHI-231. Immunogenetics 56:849-53
Klasen, Maik; Spillmann, Freia J X; Lorens, James B et al. (2005) Retroviral vectors to monitor somatic hypermutation. J Immunol Methods 300:47-62
Spillmann, Freia J X; Wabl, Matthias (2004) Endogenous expression of activation-induced cytidine deaminase in cell line WEHI-231. J Immunol 173:1858-67
Wechsler, Thomas; Chen, Benjamin P C; Harper, Ryan et al. (2004) DNA-PKcs function regulated specifically by protein phosphatase 5. Proc Natl Acad Sci U S A 101:1247-52

Showing the most recent 10 out of 16 publications